Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Busque, Lambert  [Clear All Filters]
2015
Sirhan S, Busque L, Foltz L, Grewal K, Hamm C, Laferriere N, Laneuville P, Leber B, Liew E, Olney HJ, et al. Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group. Clin Lymphoma Myeloma Leuk. 2015.
2016
Buscarlet M, Tessier A, Provost S, Mollica L, Busque L. Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2. Exp Hematol. 2016.
2020
Busque L, Sun M, Buscarlet M, Ayachi S, Zada YFeroz, Provost S, Bourgoin V, Mollica L, Meisel M, Hinterleitner R, et al. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2020;4(11):2430-2438.
Claveau J-S, Cohen S, Ahmad I, Delisle J-S, Kiss T, Lachance S, Sauvageau G, Busque L, Brito R-M, Bambace N, et al. Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors. Eur J Haematol. 2020.
Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, et al. UM171-expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections. Biol Blood Marrow Transplant. 2020.
2021
Massey V, Martel V, Nguyen DKhoa, Busque L, Chapdelaine H, Keezer MRobert. Acute central nervous system graft-versus-host-disease after liver transplantation. Transpl Immunol. 2021:101521.
2022
Shin T-H, Zhou Y, Chen S, Cordes S, Grice MZ, Fan X, Lee B-C, AlJanahi AA, Hong SGun, Vaughan KL, et al. Macaque Clonal Hematopoiesis Model Demonstrates Expansion of TET2-Disrupted Clones and Utility for Testing Interventions. Blood. 2022.